Detalhe da pesquisa
1.
[Diffuse large B-cell lymphoma concurrent with Kaposi's sarcoma in the same lymph node in a human immunodeficiency virus-negative patient].
Rinsho Ketsueki
; 65(2): 74-77, 2024.
Artigo
em Japonês
| MEDLINE | ID: mdl-38448001
2.
[Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders].
Rinsho Ketsueki
; 64(2): 133-136, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-36990734
3.
[Outcomes of COVID-19 due to omicron variant infection complicated with hematological disorders].
Rinsho Ketsueki
; 64(1): 3-8, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-36775303
4.
[Complete response with tirabrutinib for relapsed and refractory Bing-Neel syndrome].
Rinsho Ketsueki
; 63(7): 770-775, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35922946
5.
[Novel germline SAMD9 mutation in an elderly patient with myelodysplastic syndrome].
Rinsho Ketsueki
; 63(8): 865-869, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-36058856
6.
[SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders].
Rinsho Ketsueki
; 63(4): 247-253, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-35491212
7.
[Severe thrombocytopenia after COVID-19 mRNA vaccination].
Rinsho Ketsueki
; 62(12): 1684-1687, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-35022337
8.
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.
Intern Med
; 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171874
9.
Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient.
Intern Med
; 61(14): 2215-2219, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850990
10.
Repeated treatment with gefitinib and alectinib in a patient with multiple EGFR-mutant and ALK-mutant lung adenocarcinomas: A case report.
Respir Med Case Rep
; 32: 101378, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33732615